Navigating The Blood-Brain Barrier: An Interview With AngioChem CEO Jean-Paul Castaigne
This article was originally published in The Pink Sheet Daily
Executive Summary
Castaigne talks about combining AngioChem’s proprietary technology with cytotoxins, mAbs, siRNA and peptides to create therapies for cancer and neurodegenerative diseases and, oh yes, to solve the obesity problem.